Gene Query: SYBU

Dataset Description Geneva Score
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 99.16
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 58.32
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 52.56
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 52.56
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 48.07
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 44.39
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 31.04
NR2F2 study 31.04
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 29.04
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 25.41
Transcriptional profiles of normal human mature B cells 23.22
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 23.15
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 23.15
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 22.77
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 21.13
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 20.39
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 19.59
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 17.77
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 17.36
Seletive inhibition of CDK9 in DLBCL cell lines 17.09
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 16.39
Genome wide expression change in LCC2 and MCF-7 cells 16.33
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 16.29
Paxillin regulates genomic networks in prostate cancer [LNCaP] 15.58
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 15.03
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 14.88
CHCHD2 gene KO effect in iPSC drived motor neurons 14.02
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 13.59
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 13.06
RNA-sequencing of human liver tissue 13.04
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 12.81
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 12.61
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 12.06
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 12.06
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 11.92
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 11.56
Primary human trophoblast from term placenta 11.44
Gene expression in PANC1 cells treated with Rakicidin 11.24
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 10.97
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 10.71
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 10.7
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 10.42
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 10.42
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 10.36
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 10.24
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 10.03
Widespread intronic polyadenylation diversifies immune cell transcriptomes 9.49
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 9.47
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 9.47
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 9.22
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 9.22
CHCHD10 gene KO effect in iPSC drived motor neurons 9.15
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 8.98
Regionally specified human pluripotent stem cell-derived astrocytes 8.91
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 8.74
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 8.74
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 8.74
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 8.59
Next Generation Sequencing of human SMA and healthy control Motor Neurons 8.57
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 8.55
Transcriptome analysis of BAP1 knockout and restoration 8.45
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 8.45
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 8.4
Disruption of GRIN2B impairs differentiation in human neurons 8.31
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 8.23
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 7.94
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 7.94
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 7.92
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.33
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.33
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 7.26
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 7.1
Gene expression analysis of immortalized human liver progenitor-like cells in culture 6.98
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 6.75
Examining serotonergic neuron differentiation from human iPSCs 6.73
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.68
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.68
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 6.58
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 6.58
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 6.56
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 6.37
Effect of drugs on transcriptomic profiles 6.34
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 6.33
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 6.15
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 6.14
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 6.13
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 6.13
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.11
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.11
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 6.08
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 5.94
G-quadruplex structures mark human regulatory chromatin 5.82
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 5.82
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 5.8
Multiple sclerosis and EAE 5.71
Human optic chiasm from healthy controls and multiple sclerosis patients 5.71
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 5.64
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 5.64
Induced DNA demethylation, genome instability and transcription 5.64
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 5.63
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 5.63
Zika infected neural stem cells 5.61
Transcriptome analysis of Zika infected neural stem cells 5.61
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 5.47
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 5.47
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 5.32
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 5.32
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 5.29
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 5.29
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 5.29
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 5.28
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 5.21
Genome wide expression change by RNF168 knocking down in NEC cells 5.21
Conservative alteration of chromosomal expression pattern across human solid tumor types 5.03
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 5.02
Genome-wide functional assessment of enhancer activities in the human genome 5.02
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 4.95
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 4.93
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 4.93
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 4.91
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 4.9
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.89
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 4.86
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 4.85
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 4.85
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.84
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 4.82
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 4.78
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 4.76
Repurposing of promoters and enhancers during mammalian evolution 4.74
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 4.74
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 4.73
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.71
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 4.54
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 4.54
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 4.51
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 4.51
Novel Targeting of Transcription and Metabolism in Glioblastoma 4.46
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 4.44
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.43
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 4.42
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.4
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 4.38
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 4.38
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 4.38
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 4.29
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 4.26
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 4.19
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 4.19
Identification of HOXB13 target genes responsive to BET inhibitors 4.17
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 4.17
HEK293 TFAM Knockout Expression Study 4.16
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.14
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 4.05
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 4.02
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 4.0
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 3.97
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 3.97
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 3.94
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 3.91
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.91
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 3.9
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 3.82
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 3.82
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 3.81
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 3.8
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.73
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 3.7
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 3.69
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.65
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 3.62
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.62
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 3.56
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.56
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.56
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.56
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 3.56
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 3.53
Identifying the molecular mode of action of itraconazole in colorectal cancer 3.48
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 3.4
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 3.4
Paxillin regulates genomic networks in prostate cancer [C4-2] 3.38
Expression profiling of MCF-7 cells with treatment of TCDD 3.35
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.35
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 3.34
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 3.33
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 3.33
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 3.33
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.33
PNET animal model: new insights (II) 3.33
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 3.31
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 3.3
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.29
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 3.28
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 3.28
Mapping interactions for the TNIP2 hub protein 3.28
RNAseq in Alzheimer's Disease patients 3.26
Transcriptome analysis of human lung epithelial cells 3.26
Recovery and analysis of nascent RNA 3.25
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 3.25
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.24
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 3.23
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.14
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 3.13
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 3.12
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 3.12
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 3.11
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.07
FGF2 regulation of gene expression in stable inducible Neurons 3.05
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 3.0
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 2.94
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 2.93
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 2.93
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 2.92
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 2.91
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.91
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 2.87
Differential Gene Expression between MCF10A and MCF7 cells 2.87
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.85
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 2.81
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 2.81
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.79
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.77
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.77
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 2.76
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 2.74
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 2.71
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 2.71
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 2.7
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 2.7
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.69
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 2.69
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 2.66
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.64
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 2.62
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 2.57
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 2.57
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.56
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.56
R430: A potent inbibitor of DNA and RNA viruses 2.53
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 2.52
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 2.52
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 2.52
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.49
Molecular analysis of renal cell carcinoma with unclassfied histology 2.49
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 2.48
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 2.48
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 2.48
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 2.46
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 2.46
circRNA-sequencing 2.45
Illumina Total RNA-seq in HeLa 2.44
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 2.44
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 2.44
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 2.43
Functional astrocytes differentiated from hiPSCs 2.42
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 2.42
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.41
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 2.41
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 2.41
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 2.4
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 2.38
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 2.38
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 2.38
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 2.37
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 2.37
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 2.36
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 2.35
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 2.34
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 2.33
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 2.32
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 2.32
Gene expression profiling in metabolically heterogeneous human lung tumors 2.31
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 2.3
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 2.3
ARID1A and ARID1B loss in HCT116 cells 2.3
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 2.24
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 2.23
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.21
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 2.21
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.2
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 2.19
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 2.19
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 2.17
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 2.16
Changes in human endometrial gland transcriptome over the window of implantation 2.15
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.14
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 2.13
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.12
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.11
Loss of endometrial plasticity in recurrent pregnancy loss 2.11
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.1
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 2.09
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 2.08
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.07
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 2.07
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 2.04
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.03
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.02
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.02
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.02
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 2.0
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 2.0
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 1.99
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.96
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.96
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 1.95
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 1.95
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 1.94
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 1.94
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 1.93
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 1.93
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.91
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.91
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 1.91
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.91
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.91
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.9
RNA-seq analysis of control and Myc-induced U2OS cells 1.88
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 1.85
The age and genomic integrity of neurons after cortical stroke in humans 1.83
RNA-Seq of the corpus callosum from 12 individuals 1.83
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 1.8
NKX2.2 1.8
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 1.79
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  1.78
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 1.77
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.73
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 1.73
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 1.73
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.7
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.67
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.66
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 1.63
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.63
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.61
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.61
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.61
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 1.58
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.56
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.52
mRNA-sequencing of breast cancer subtypes and normal tissue 1.51
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 1.5
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.5
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.47
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.46
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 1.46
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 1.46
Effect of BMP inhibition or stimulation of primary human keratinocytes 1.45
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 1.45
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.43
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 1.42
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.41
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 1.4
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 1.4
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.39
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 1.39
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 1.38
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.38
Discovering human diabetes-risk gene function with genetics and physiological assays 1.37
LIN28A Over-expression RNAseq 1.33
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.33
Human islets of varying quality: the good, the (not so) bad and the ugly 1.31
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.3
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.3
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.28
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.26
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.24
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.24
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.21
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 1.19
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 1.15
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 1.14
The circadian transcriptional landscape in primary human mammary epithelial cells 1.14
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.13
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.12
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 1.03
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.01
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 1.0
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 1.0
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.99
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.99
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.99
The gene expression profiles of gallbladder cancer 0.97
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.97
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 0.97
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.95
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 0.94
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 0.92
BASP1 modifies the Tamoxifen response 0.91
mRNA sequencing of oropharyngeal cancer cell lines 0.9
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.86
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.86
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.84
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 0.84
Reprogrammed myeloid cell transcriptomes in NSCLC 0.84
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.83
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.83
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.81
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 0.81
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.79
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.79
Hepatic transcriptome of pediatric hepatoblastoma. 0.78
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.75
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.74
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.74
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.71
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.69
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.69
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 0.68
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.68
Evaluating pre-clinical models for studying NASH driven HCC. 0.67
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.67
Dermal endothelial cells of type 2 diabetic patients 0.66
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.64
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.64
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.63
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.61
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.61
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.61
The Glioma-Infiltrating T Cell Receptor Repertoire 0.6
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.59
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 0.59
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 0.59
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 0.58
RNA seq analysis of human Fetal and adult derived Enterospheres 0.58
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.58
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.57
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.57
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 0.56
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 0.56
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.56
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 0.56
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.53
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.53
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.51
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.51
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.51
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.5
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.5
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.45
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.45
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.45
RNA-Seq in PWS iPSC-derived neurons 0.43
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 0.41
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.38
Energy Metabolism during Anchorage-Independence 0.37
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 0.36
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 0.36
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.36
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 0.35
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.35
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 0.34
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.32
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.31
RNA Seq of Alagille liver biopsies 0.3
Alagille_Nodder 0.3
hNSCs siRNA NOVA2 0.3
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 0.3
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.28
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.27
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.26
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.24
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.23
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.22
Transcriptome-wide modulation of splicing by the exon junction complex 0.22
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.22
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.21
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 0.21
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.21
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.21
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.21
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.2
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.19
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.19
RNAseq of Breast cancer PDX samples 0.18
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.18
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.18
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.14
Gene expression analysis of human hepatocellular cancers 0.13
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.11
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.11
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.1
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 0.1
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.1
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.09
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.09
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.09
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.08
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 0.08
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.07
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.06
Effect of nuclear IL-33 on gene expression 0.06
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.04
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 0.04
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.04
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.04
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.02
Ribosomal protein RPL26 is the principal target of UFMylation 0.01
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation